GNPX (STOCKS)
Genprex, Inc. Common Stock
$5.050000
+0.320000 (+6.77%)
Prev close: $4.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ryan M. Confer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.46M
- Employees
- 15
- P/E (TTM)
- -0.01
- P/B (TTM)
- 0.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.64 | $0.00 | +0.0000 | +0.00% |
|
Mar 2025 (Q1)
|
$-286.00 | $-460.02 | +174.0200 | +37.83% |
|
Dec 2024 (Q4)
|
$-1,265.00 | $-437.58 | -827.4200 | -189.09% |
|
Sep 2024 (Q3)
|
$-1,353.00 | $-2,165.46 | +812.4600 | +37.52% |
Financial Statements
| Revenues | $0.00 |
| Costs And Expenses | $16.04M |
| Research and Development | $9.63M |
| Operating Income/Loss | -$16.04M |
| Income/Loss From Continuing Operations After Tax | -$16.73M |
| Income/Loss From Continuing Operations Before Tax | -$16.03M |
| Net Income/Loss | -$16.73M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$16.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$16.73M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.21 |
| Basic Average Shares | 35,698,273 |
| Assets | $20.31M |
| Current Assets | $18.80M |
| Noncurrent Assets | $1.50M |
| Liabilities | $3.38M |
| Current Liabilities | $3.35M |
| Noncurrent Liabilities | $22.50K |
| Equity | $16.93M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $16.93M |
| Liabilities And Equity | $20.31M |
| Net Cash Flow From Operating Activities | -$14.29M |
| Net Cash Flow From Operating Activities, Continuing | -$14.29M |
| Net Cash Flow From Investing Activities | -$14.58M |
| Net Cash Flow From Investing Activities, Continuing | -$14.58M |
| Net Cash Flow From Financing Activities | $28.87M |
| Net Cash Flow From Financing Activities, Continuing | $28.87M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$16.73M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$16.73M |
| Other Comprehensive Income/Loss | $0.00 |